CAMBRIDGE, Mass–Ultivue, a venture-backed company developing reagent-driven solutions for high-performance biological imaging in situ, has announced today that it has closed a $20 million Series B funding round led by existing investor ARCH Venture Partners. New participating investors accounted for approximately half of the investment and included 6 Dimensions Capital, a recent merger of WuXi […]
IONTAS to generate antibodies with favourable, binding and expression properties using their Mammalian Display Antibody Discovery Platform Cambridge, UK: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced today that it has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology. IONTAS’ […]
-Conference Call and Webcast Scheduled for Tuesday, January 23 at 7:30 AM ET- HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has entered into a definitive merger agreement to acquire 100% of the outstanding stock of Data Sciences […]
Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization. SALT LAKE CITY Carterra Inc., an innovative label-free biosensor company, has announced the closing of a $10M financing from Telegraph Hill Partners (THP). The proceeds will be used to complete development and commercialize the Company’s LSA™ instrument, a fully automated, high-throughput […]
Munich, Germany – Achieve fast staining and immediate functional analysis of filamentous actin (F-actin) in living and fixed cells with ibidi’s new reagent, LifeAct-TagGFP2 Protein. The addition of this recombinant protein extends the successful ibidi LifeAct product line for F-actin visualization and offers an interesting, non-toxic and non-invasive alternative to phalloidin. F-actin is a key component of […]
Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The new Gyrolab® Generic TK Kit adds to a growing […]
SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology
Lightning-Link is now available in volumes from 10µg to 100mg Direct-labeling technology provides excellent batch-to-batch consistency and high performance Bulk supply of ultra-high quality Lightning-Link raw materials also now available Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today […]
MINNEAPOLIS — Bio-Techne now offers reagents and kits from Vector Laboratories, a leader in advanced labeling and detection solutions. Their innovative proprietary immunolabeling kits offer reliable, sensitive, and low background detection. In October 2017, Bio-Techne started distributing Vector Laboratories’ flagship products to complement its vast selection of Novus Biologicals® primary antibodies, including over 13,000 monoclonal- and […]
MUNICH, Germany — NanoTemper Technologies, the maker of life science tools for protein characterization, launched its latest system, Tycho NT.6, at the PepTalk conference in San Diego. Any researcher working with proteins that experiences irreproducible results needs Tycho to identify the quality of their starting material in order to prevent unnecessary experiments and questionable data. “Tycho provides a very useful […]
The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced a collaboration to develop a novel analytical platform to improve the rapid analysis of the glycosylation profiles of biotherapeutics. This is a critical quality attribute which is important for the efficacy and safety of these molecules. The consortium brings […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
